| Typ : |
Časopis |
| internetový odkaz : |
http://archive.hospital-pharmacy.com/doi/ref/10.1310/hpj5007-609 |
|
| výskumné tímy : |
San Francisco - Theravance Biopharma |
| Autori : |
Gu Z, Wong A, Raquinio E, Nguyen A. |
| titul : |
Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags. |
| Référence : |
Hosp Pharm ; 50, 7: 609-614. 2015 |
|
| Úroveň dôkazu : |
|
| fyzikálna stabilita : |
|
| chemická stabilita : |
|
| iné metódy : |
|
| Komentáre : |
| Degradačné produkty sú identifikované a kvantifikované |
|
Zoznam zlúčenín
 Telavancin hydrochloride
|
 |
 |
 |
 |
0.6 mg/ml |
-20°C |
 |
| 32 |
 |
|
|
|
|
|
8 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
 |
0.6 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
|
8 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
 |
|
0.6 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
|
8 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
|
0.6 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
|
8 mg/ml |
-20°C |
|
| 32 |
|
|
|
|
|
